Why is "Renal cell carcinoma" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-30 20:11:44
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases. It is more common in men. It is most commonly diagnosed in the elderly.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Kidney cancer specialists: 3 things to know about renal cell carcinoma (RCC) - UT MD Anderson
-
Belzutifan Plus Lenvatinib Versus Cabozantinib for Advanced Renal Cell Carcinoma After Anti–PD-(L)1 Therapy: Open-Label Phase 3 LITESPARK-011 Study - OncLive
-
Renal Cell Carcinoma: Background, Pathophysiology, Etiology - Medscape
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma - NEJM
-
ASCO GU 2026: Emerging Tools in Imaging in Renal Cell Carcinoma - UroToday
-
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma - Nature
-
What Is Papillary Renal Cell Carcinoma? - Verywell Health
-
Renal cell carcinoma containing fat: demonstration with CT.Radiology - RSNA Journals
-
PD-L1 Plus CTLA-4 Inhibition for Renal Cell Carcinoma Following Resection: RAMPART - The ASCO Post
-
Navigating the Treatment Landscape in Non–Clear Cell Renal Cell Carcinoma - Targeted Oncology
-
A multimodal AI model for precision prognosis in clear cell renal cell carcinoma: A multicenter study - Nature
-
Recent Advances in Different Subtypes of Renal Cell Carcinoma - OncLive
-
Deciphering genetic susceptibility to clear cell renal cell carcinoma | Communications Biology - Nature
-
Belzutifan-Based Combinations Meet DFS, PFS End Points in Renal Cell Carcinoma - OncLive
-
Prognostic comparison of partial and radical nephrectomy for T1b renal cell carcinoma with SEER database analysis - Nature
-
fibroblasts orchestrate tumor microenvironment remodeling in renal cell carcinoma with tumor thrombus - Nature
-
LncRNA DRAIC facilitates the progression of renal cell carcinoma by modulting the microRNA-145-3p/ABRACL pathway signaling - Nature
-
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors - Nature
-
Identification of biomarkers for renal cell carcinoma in plasma samples measured using liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry - Nature
-
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial - Nature
-
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study - Nature
-
Case Report: Papillary renal cell carcinoma complicated by ipsilateral renal tuberculosis - Frontiers
-
Gallbladder Metastasis Originating from Renal Cell Carcinoma - The American College of Surgeons
-
Adaptations of lipid metabolism in low-grade clear cell renal cell carcinoma are linked to cholesteryl ester accumulation - Nature
-
Integrated analysis of MIOX gene in prognosis of clear-cell renal cell carcinoma | Cell Death & Disease - Nature
-
Enhanced staging of renal cell carcinoma using tumor morphology features: model development and multi-source validation - Nature
-
ASCO 2025: ALLO-316 in Advanced Clear Cell Renal Cell Carcinoma: Updated Results from the Phase 1 TRAVERSE Study - UroToday
-
Identifying potential risk genes for clear cell renal cell carcinoma with deep reinforcement learning - Nature
-
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets - Nature
-
MLN4924 suppresses tumor metabolism and growth of clear cell renal cell carcinoma by stabilizing nuclear FBP1 - Nature
-
Biomarker-informed care for patients with renal cell carcinoma - Nature
-
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma - Nature
-
Prognostic significance of circulating tumor DNA alterations in advanced renal cell carcinoma from SCRUM-Japan MONSTAR-SCREEN: a nationwide genomic profiling project | British Journal of Cancer - Nature
-
From Challenges to Cures: Improving Outcomes in Patients With Renal Cell Carcinoma - ASCO Publications
-
Cancer trial: Merck combo cuts renal cell cancer recurrence 28% - stocktitan.net
-
Renal cell carcinoma - The Lancet
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma - NEJM
-
HIF-2α Inhibitors Make Significant Inroads in Renal Cell Carcinoma - Targeted Oncology
-
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma - NEJM
-
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma - Nature
-
Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression - Nature
-
Renal cell carcinoma treatment: What’s new and what's next - UT MD Anderson
-
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - NEJM
-
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease - NEJM
-
Renal-Cell Carcinoma - NEJM
-
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma - NEJM
-
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma - Nature
-
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma - NEJM
-
Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort - Nature
-
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma - NEJM
-
Face to Face With Renal Cell Carcinoma: A Case Report - Cureus
-
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma - NEJM
-
Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma - Nature
-
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort | npj Precision Oncology - Nature
-
BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma - Nature
-
Network-based metabolic characterization of renal cell carcinoma - Nature
-
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma - NEJM
-
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma - Nature
-
Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy - Frontiers
-
The effect of the papillary renal cell carcinoma subtype on oncological outcomes - Nature
-
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma - NEJM
-
Navigating Frontline Treatment of Advanced Non–Clear Cell Renal Cell Carcinoma - ASCO Daily News
-
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway - Nature
-
Renal cell carcinoma - Nature
-
S100A2 promotes clear cell renal cell carcinoma tumor metastasis through regulating GLUT2 expression - Nature
-
Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study - Nature
-
Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features - Nature
-
Metabolic alterations in hereditary and sporadic renal cell carcinoma - Nature
-
Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma - NEJM
-
Overview of Renal Cell Carcinoma - OncLive
-
Kick-Starting Molecular Theranostics in Renal Cell Carcinoma - Journal of Nuclear Medicine
-
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality - Nature
-
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma - NEJM
-
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints | npj Precision Oncology - Nature
-
Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype - Nature
-
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma - NEJM
-
Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor - Nature
-
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial - Nature
-
Epigenomic charting and functional annotation of risk loci in renal cell carcinoma - Nature
-
Renal Cell Carcinoma in Pregnancy: A Case Report of a Rare Diagnosis - Cureus
-
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature
-
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma - NEJM
-
Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients - Nature
-
FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway | Scientific Reports - Nature
-
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy - NEJM
-
Renal cell carcinoma - The Lancet
-
Determinants of renal cell carcinoma invasion and metastatic competence - Nature
-
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma - NEJM
-
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes - Nature
-
Towards individualized therapy for metastatic renal cell carcinoma - Nature
-
Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma - Nature
-
Scalp Metastasis From Renal Cell Carcinoma: A Rare Case With Rapid Progression - Cureus
-
Translocation renal cell carcinoma says no to the Warburg effect - Nature
-
Proteogenomic characterization of MiT family translocation renal cell carcinoma - Nature
-
The role of RNA-modifying proteins in renal cell carcinoma - Nature
-
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma - Nature
-
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma - Nature
-
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma - NEJM
-
Considerations When Treating Patients With Metastatic Renal Cell Carcinoma - OncLive
-
Renal cell carcinoma study shows excellent short-term outcomes without adjuvant therapy - Children's National Hospital
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.